Compare CMTL & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMTL | ICCM |
|---|---|---|
| Founded | 1967 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 45.5M |
| IPO Year | N/A | N/A |
| Metric | CMTL | ICCM |
|---|---|---|
| Price | $3.19 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $2.50 |
| AVG Volume (30 Days) | 195.1K | ★ 375.3K |
| Earning Date | 12-11-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $494,760,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $5.15 | $38.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $0.59 |
| 52 Week High | $4.88 | $1.66 |
| Indicator | CMTL | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.44 | 39.01 |
| Support Level | $3.17 | $0.67 |
| Resistance Level | $3.73 | $0.72 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 25.56 | 5.66 |
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.